252 related articles for article (PubMed ID: 12532083)
1. Inflammatory cells in asthma: mechanisms and implications for therapy.
Hamid Q; Tulic' MK; Liu MC; Moqbel R
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S5-S12; discussion S12-7. PubMed ID: 12532083
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
[TBL] [Abstract][Full Text] [Related]
5. [Cysteinyl-leukotrienes: important mediators in asthma].
Louis R; Neven I; Quadvlieg V; Bettiol J; Radermecker M
Rev Med Liege; 1997 Sep; 52(9):598-602. PubMed ID: 9441344
[No Abstract] [Full Text] [Related]
6. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
7. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
8. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
9. New clues to asthma therapies.
Vogel G
Science; 1997 Jun; 276(5319):1643-6. PubMed ID: 9206826
[No Abstract] [Full Text] [Related]
10. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
Shum BO; Rolph MS; Sewell WA
Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies for asthma--advances and problems.
Walsh GM
Curr Pharm Des; 2005; 11(23):3027-38. PubMed ID: 16178761
[TBL] [Abstract][Full Text] [Related]
12. New perspectives for asthma treatment: anti-leukotriene drugs.
García-Marcos L; Schuster A
Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
[TBL] [Abstract][Full Text] [Related]
13. Montelukast in allergic diseases beyond asthma.
Leonardi S; Marchese G; Marseglia GL; La Rosa M
Allergy Asthma Proc; 2007; 28(3):287-91. PubMed ID: 17619556
[TBL] [Abstract][Full Text] [Related]
14. Anti-leukotrienes for asthma.
Calhoun WJ
Curr Opin Pharmacol; 2001 Jun; 1(3):230-4. PubMed ID: 11712744
[TBL] [Abstract][Full Text] [Related]
15. [Research on inflammatory mediators in asthma: new therapeutic approaches].
Magnan A; Molimard M; Braunstein G; Devillier P
Therapie; 1999; 54(4):447-61. PubMed ID: 10667111
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, inflammatory mediators, and mediator antagonists in asthma.
Lazarus SC
J Clin Pharmacol; 1998 Jul; 38(7):577-82. PubMed ID: 9702841
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
19. Role of mast cells and basophils in asthma.
Redington AE; Polosa R; Walls AF; Howarth PH; Holgate ST
Chem Immunol; 1995; 62():22-59. PubMed ID: 7546283
[No Abstract] [Full Text] [Related]
20. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
